Health Research Board, Ireland. Department of Health. (2024) HRB National Drugs Forum 2024 - programme. Dublin: Health Research Board.
Preview | Title | Contact |
---|---|---|
|
PDF (HRB National Drugs Forum 2024 - programme)
255kB |
Emerging drug trends: monitoring, communicating, and responding. The National Drugs Forum 2024, which took place in November, focused on creating awareness around early warning systems on new drugs and emerging trends. The European Union Drugs Agency have developed a well-coordinated system of communication and robust mechanism to provide the European Commission with scientific advice on control decisions. Progress in these areas will depend on the development of national early warning systems, and this will need creation of new monitoring tools, such as wastewater analysis and drug checking services.
Link to 3-minute visual summary of the National Drugs Forum 2024
Link to National Drugs Forum webpage.
National Drugs Forum 2024 programme:
09:30 |
Registration opens |
10:00 – 10:20 |
Professor Eamon Keenan, Health Service Executive (HSE), Monitoring Emerging Drug Trends in Ireland |
10:20 – 10:40 |
Dr Rachel Christie, European Union Drugs Agency (EUDA) Developments in analytical techniques to support early warning and risk assessment |
10.40 – 11.00 |
Vicki Craik, Rapid Action Drug Alerts and Response (RADAR) RADAR: Developing early warning drugs surveillance as part Scotland’s public health system |
11.00 – 11:30 |
Break |
11.30 – 12.45 |
Marketplace 1 |
Sinead McNamara, HSE National Drug Treatment Centre, HSE |
|
12:45 – 13:45 |
Lunch |
13.45 – 15.00 |
Marketplace 2 |
Nicki Killeen, Drug checking and festival outreach, HSE |
|
15.00 – 15.30 |
Close |
Speakers:
|
Prof Eamon Keenan has been working as the HSE national clinical lead of addiction services since 2016. He is a consultant psychiatrist in substance misuse, and a clinical professor in addiction studies at Trinity College Dublin. He has been working in this area for over 30 years and has published extensively in peer reviewed medical journals. He is one of the Irish representatives on the management board of the EUDA. He has a keen interest in the area of emerging drug trends and recently coordinated the Irish response to a number of overdose clusters associated with synthetic opioids. |
|
Dr Rachel Christie is a chemist with a Bachelor’s degree in forensic and environmental chemistry and a PhD in ‘The analysis, synthesis and characterisation of new psychoactive substances of abuse’. She has worked at the European Union Drugs Agency (EUDA), previously the EMCDDA, for more than ten years in the action on new drugs sector as a principal scientific analyst, with responsibility for the day-to-day operation of the EU Early Warning System on new psychoactive substances. |
|
Vicki Craik is a public health intelligence adviser within the drugs team at Public Health Scotland (PHS). In this role, she manages Scotland’s drugs early warning system and supports the development of drug surveillance in Scotland, including hospital toxicology and drug checking. Vicki trained as a research and development scientist, and prior to joining PHS she worked for a national front-line drug service where she specialised in emerging drugs trends and new psychoactive substances. |
J Health care, prevention, harm reduction and treatment > Risk and needs assessment > Risk assessment > Early warning monitoring system
J Health care, prevention, harm reduction and treatment > Identification and screening > Identification and screening for substance use
VA Geographic area > Europe > Ireland
Repository Staff Only: item control page